Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
"Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract." Current Pharmaceutical Design
Researchers choose BPC-157 for its uniquely broad profile: it accelerates tissue repair , drives new blood-vessel formation , and protects gastrointestinal lining , all within a single peptide
The Phase 2 trial reported that 72% of participants with prediabetes at baseline reverted to normoglycemia
GHK-Cu (sister peptide) delivered by repeated subcutaneous injection into rat wound chambers produced concentration-dependent increases in collagen, glycosaminoglycans, protein and DNA primary in-vivo evidence that the copper-tripeptide class is bioactive by injection in animals, but for GHK-Cu, not AHK-Cu
US$ 22.70
US$ 24.53
US$ 21.84
US$ 26.95
.png)
